Global Cancer Pain Therapeutics Market 2015-2019

癌性疼痛治療薬の世界市場2015-2019

◆タイトル:Global Cancer Pain Therapeutics Market 2015-2019
◆商品コード:IRTNTR7585
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2016年1月20日
◆ページ数:61
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、癌性疼痛治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、疾患概要、癌性疼痛治療薬の世界市場規模及び予測、種類別分析、地域別分析/市場規模、パイプライン分析、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Cancer Pain Therapeutics

Cancer pain can be acute or chronic, depending on its stages and types. Cancer pain is caused by the tumor pressing against bones, nerves, or other organs in an individual’s body. Pain control is imperative not only for people who have advanced cancer but also for those whose condition remains stable for years. Pharmaceutical interventions such as non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and adjuvant pain medications are used to treat cancer pain.

Technavio’s analysts forecast the global cancer pain therapeutics market to grow at a CAGR of 9.08% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global cancer pain therapeutics market for 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of cancer pain.
The market is divided into the following segments based on region:
• Americas: The US, Canada, Mexico, and Brazil
• EMEA: The UK, Germany, Italy, France, Spain, Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE
• APAC: Japan, China, Australia, Singapore, South Korea, and India

Technavio’s report, Global Cancer Pain Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• BioDelivery Sciences
• ProStrakan Group
• Teva Pharmaceuticals
• Yamaha

[Other prominent vendors]
• Daiichi Sankyo
• Eli-lilly
• Galena Biopharma
• Grunenthal Group
• GW Pharmaceuticals
• Hospira
• Johnson & Johnson
• Meda Pharmaceuticals
• Orexo
• Sanofi
• Sorrento Therapeutics
• WEX Pharmaceuticals

[Market driver]
• Unmet medical needs
• For a full, detailed list, view our report

[Market challenge]
• Off-label drug use
• For a full, detailed list, view our report

[Market trend]
• Increase in awareness
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Disease overview
• Understanding the disease
• Signs and symptoms
• Causes of cancer pain
• Assessment of cancer pain
• Treatment
• Epidemiology

PART 06: Pipeline portfolio
• Information on pipeline candidates

PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 08: Market segmentation by drug class
• Opioids
• Non-steroidal anti-inflammatory drugs
• Others

PART 09: Geographical segmentation
• Cancer pain therapeutics market in Americas
• Cancer pain therapeutics market in EMEA
• Cancer pain therapeutics market in APAC

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape
• Competitive scenario
• Market analysis 2014

PART 16: Vendor landscape
• Other prominent vendors

PART 17: Key vendor analysis
• BioDelivery Sciences
• ProStrakan
• Teva Pharmaceuticals

PART 18: Appendix
• List of abbreviations

PART 19: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Classification of cancer pain
Exhibit 03: Acute pain syndromes
Exhibit 04: Chronic pain syndromes
Exhibit 05: Causes of pain from cancer
Exhibit 06: Causes of pain from procedures and surgery
Exhibit 07: Causes of pain from other cancer treatments
Exhibit 08: Common causes of pain in cancer patients
Exhibit 09: Cancer pain assessment
Exhibit 10: Types of pain scales
Exhibit 11: Treatment options for cancer pain
Exhibit 12: Commonly used non-opioids for pain management
Exhibit 13: Commonly used adjuvant medicines for cancer pain
Exhibit 14: Management of cancer pain
Exhibit 15: Pipeline molecules for cancer pain therapeutics market
Exhibit 16: Global cancer pain therapeutics market ($ millions)
Exhibit 17: Five forces analysis
Exhibit 18: Global cancer pain therapeutics market by drug class
Exhibit 19: Global cancer pain therapeutics market by geographical segmentation 2014
Exhibit 20: Cancer pain therapeutics market in different regions, 2014-2019 ($ millions)
Exhibit 21: Cancer pain therapeutics market in the Americas 2014-2019 ($ millions)
Exhibit 22: Cancer pain therapeutics market in EMEA 2014-2019 ($ millions)
Exhibit 23: Cancer pain therapeutics market in APAC 2014-2019 ($ millions)
Exhibit 24: Impact of drivers
Exhibit 25: Impact of drivers and challenges
Exhibit 26: BioDelivery Sciences: Key takeaways
Exhibit 27: ProStrakan: Key takeaways
Exhibit 28: Teva Pharmaceuticals: Key takeaways
Exhibit 29: BioDelivery Sciences: Product pipeline
Exhibit 30: Teva Pharmaceuticals: Business segmentation by revenue 2014
Exhibit 31: Teva Pharmaceuticals: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 32: Teva Pharmaceuticals: Geographical segmentation by revenue 2014



【掲載企業】

BioDelivery Sciences, ProStrakan Group, Teva Pharmaceuticals, Daiichi Sankyo, Eli-lilly, Galena Biopharma, Grunenthal Group, GW Pharmaceuticals, Hospira, Johnson & Johnson, Meda Pharmaceuticals, Orexo, Sanofi, Sorrento Therapeutics, WEX Pharmaceuticals.

【資料のキーワード】

がん性疼痛、癌性疼痛治療薬、オピオイド、医薬品、パイプライン

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[癌性疼痛治療薬の世界市場2015-2019] (Global Cancer Pain Therapeutics Market 2015-2019 / IRTNTR7585)販売に関する免責事項
[癌性疼痛治療薬の世界市場2015-2019] (Global Cancer Pain Therapeutics Market 2015-2019 / IRTNTR7585)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆